The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

Immunogenicity of Prevnar 20 in Adults Previously Vaccinated With Pneumococcal Vaccine Randomized, open-label trial evaluated immune responses to Prevnar 20 in adults 65 years and older previously ...

Just a month after getting approval for its new pneumococcal vaccine Vaxneuvance in adults ... the basis of regulatory filing to extend the label for Vaxneuvance later this year, according ...

Amid the growing importance of pneumococcal vaccination to prevent pneumonia during the change of seasons, confusion is ...

Read all vaccine information available from your health care professional before receiving the vaccine. If you have any questions, ask your health care professional. This vaccine is given by ...

The World Health Organization (WHO) says that pneumococcal disease is the world’s number 1 vaccine-preventable cause of death among infants and children younger than 5 years of age. These may be ...

A lack of vaccination against respiratory pathogens was commonly identified among US international travelers, indicating the need to improve vaccine uptake at pre-travel visits.

EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults “Pneumococcal disease continues to pose a significant risk for adults in Europe, among adults who are ...

Special populations: Individuals considered to be at a higher risk of pneumococcal infection may receive at least one dose of Prevenar 13. Your doctor will advise the appropriate vaccination schedule.

Analysed of blood and stool samples revealed that children who were directly exposed to neonatal antibiotics, produced much lower levels of antibodies against multiple polysaccharides included in the ...